Table 4.

Flow cytometric analysis of T-cell surface markers before and 1 mo after initiation therapy

PatientHLA-DR+CD45RO+
PrePostPrePost
% of CD3+CD4+% of CD3+CD4+
35.721.864.274.2
410.911.6NANA
53.9759.769.5
619.220.46681.2
76.58.988.789.5
94.97.285.188.6
1027.927.167.367.7
123.14.49797
1385.391.994.2
1416.113.766.274.6
156.46.71.12.2
1625.324.588.788
174.78.354.666.2
188.39.882.485.4
Mean Δ ± SE+1.8 ± 1.2 (P = 0.15)+5.0 ± 1.5 (P = 0.005)
% of CD3+CD4-% of CD3+CD4-
35.310.613.721.1
45.99.4NANA
524.41518.6
615.59.29.117.6
76.972826.6
94.4822.629.6
1025.736.525.128
121.83.624.224.9
139.230.633.735.6
1420.315.716.318.6
157.47.122.3
1623.315.15.36.9
172.62.55.88.3
1826.323.413.112.7
Mean Δ ± SE+1.9 ± 2.0 (P = 0.36)+2.8 ± 0.9 (P = 0.006)

NOTE: Values compared with the use of paired two-tailed t test.

Abbreviation: NA, not available.